mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.008 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0014 |
1 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.01 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.0016 |
1 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.5 |